Today: 22 June 2026

Accenture Stock (ACN) After the Bell: Earnings Beat, AI Bookings Surge, Guidance in Focus Ahead of Friday’s Open

Accenture Stock (ACN) After the Bell: Earnings Beat, AI Bookings Surge, Guidance in Focus Ahead of Friday’s Open

Accenture shares closed Thursday at $269.96, down 1.38%, and slipped further to $268.82 in after-hours trading after issuing cautious guidance despite beating fiscal Q1 earnings estimates. Revenue rose 6% to $18.74 billion, with adjusted EPS up 10% to $3.94. The company reported $2.2 billion in advanced AI bookings but said it will stop breaking out AI metrics separately going forward.
Pfizer Stock After Hours Today (Dec. 18, 2025): PFE Holds Near $25 — What to Know Before Friday’s Market Open

Pfizer Stock After Hours Today (Dec. 18, 2025): PFE Holds Near $25 — What to Know Before Friday’s Market Open

Pfizer shares closed Thursday at $25.04 and held near that level in after-hours trading as investors weighed the company’s 2026 outlook and ongoing U.S. drug pricing policy changes. Pfizer forecast 2026 revenue between $59.5 billion and $62.5 billion, and adjusted EPS of $2.80 to $3.00. The company expects COVID-19 product sales to drop to about $5 billion in 2026.
19 December 2025
Texas Instruments Stock (TXN) After Hours: Sherman Fab Goes Live, Wall Street Targets Shift, and What to Watch Before Friday’s Open (Dec. 19, 2025)

Texas Instruments Stock (TXN) After Hours: Sherman Fab Goes Live, Wall Street Targets Shift, and What to Watch Before Friday’s Open (Dec. 19, 2025)

Texas Instruments closed Thursday at $176.19, up 0.97%, before slipping to $175.83 in after-hours trading. The company began production at its new 300mm semiconductor plant in Sherman, Texas, marking a major U.S. manufacturing milestone. Trading volume reached about 7.4 million shares during the day and 741,510 after hours. The move followed cooler-than-expected inflation data and positive sentiment in the chip sector.
Carvana Stock (CVNA) After Hours Today: Shares Hold Near $466 as CPI Rally, S&P 500 Countdown and Friday’s “Triple Witching” Loom

Carvana Stock (CVNA) After Hours Today: Shares Hold Near $466 as CPI Rally, S&P 500 Countdown and Friday’s “Triple Witching” Loom

Carvana shares closed at $465.74 on Thursday, up 4.37%, and edged to $466.12 in after-hours trading. The stock swung between $448 and $467 during the session, with about 3.9 million shares traded. The move followed a lower-than-expected November CPI reading and falling weekly jobless claims, which lifted risk-sensitive stocks.
19 December 2025
Constellation Energy (CEG) Stock After the Bell on Dec. 18, 2025: PJM Capacity Shock, FERC’s AI Data-Center Order, and What to Watch Before Friday’s Open

Constellation Energy (CEG) Stock After the Bell on Dec. 18, 2025: PJM Capacity Shock, FERC’s AI Data-Center Order, and What to Watch Before Friday’s Open

Constellation Energy closed at $361.05 on Dec. 18, up 5.9% after a volatile session, then held steady in after-hours trading. The move followed PJM’s capacity auction clearing at the $333.44/MW-day price cap and a FERC order on data-center grid connections. Investors also tracked a key step in the antitrust review of Constellation’s planned Calpine acquisition.
Salesforce (CRM) Stock After the Bell Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Deal, Analyst Targets, and What to Watch Before Friday’s Open

Salesforce (CRM) Stock After the Bell Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Deal, Analyst Targets, and What to Watch Before Friday’s Open

Salesforce closed Thursday at $257.85, slipping to about $257.30 in after-hours trading despite several new AI and M&A announcements. Shares moved little during the session, up just 0.05% as the S&P 500 gained 0.79%. Volume remained in the low millions. The company launched its Agentforce Sales app for ChatGPT, enabling CRM actions directly within the platform.
Johnson & Johnson Stock (JNJ) After Hours Today (Dec. 18, 2025): FDA Approvals, Analyst Targets, and Talc Litigation in Focus Ahead of Friday’s Open

Johnson & Johnson Stock (JNJ) After Hours Today (Dec. 18, 2025): FDA Approvals, Analyst Targets, and Talc Litigation in Focus Ahead of Friday’s Open

Johnson & Johnson shares closed Thursday at $208.31, down 0.96%, then edged up to $208.65 after hours. The company announced FDA clearance expanding TRUFILL n‑BCA’s use for chronic subdural hematoma and FDA approval for RYBREVANT FASPRO as a subcutaneous lung cancer treatment. JNJ’s market cap stands near $502 billion.
19 December 2025
Walmart Stock (WMT) After Hours Today, Dec. 18, 2025: SEC Filings, Fresh Headlines, Analyst Targets, and What to Watch Before Friday’s Open

Walmart Stock (WMT) After Hours Today, Dec. 18, 2025: SEC Filings, Fresh Headlines, Analyst Targets, and What to Watch Before Friday’s Open

Walmart shares closed at $114.83, down 0.71% Thursday, underperforming the broader market after softer U.S. inflation data. After the bell, a Form 144 filing showed the Walton Family Foundation plans to sell 350,000 shares, valued at about $40.2 million. After-hours trading remained steady near the closing price. Trading volume reached 20.8 million shares.
19 December 2025
Applied Materials (AMAT) Stock After Hours Today (Dec. 18, 2025): Analyst Upgrade Sparks a Rally—What to Know Before Friday’s Market Open

Applied Materials (AMAT) Stock After Hours Today (Dec. 18, 2025): Analyst Upgrade Sparks a Rally—What to Know Before Friday’s Market Open

Applied Materials shares rose 2.11% to $253.50 Thursday, snapping a two-day slide after B. Riley raised its price target to $305 and reiterated a Buy rating. Trading volume topped 8.4 million shares, above the 50-day average. After-hours quotes fluctuated, briefly dipping to $252.55 before recovering. The stock remains about 8% below its December 10 high of $276.10.
19 December 2025
Lam Research (LRCX) Stock After Hours Today (Dec. 18, 2025): Why Shares Jumped and What to Watch Before Friday’s Open

Lam Research (LRCX) Stock After Hours Today (Dec. 18, 2025): Why Shares Jumped and What to Watch Before Friday’s Open

Lam Research shares jumped 6.3% to $164.70 Thursday after several analysts raised price targets, with B. Riley moving to $195 and Mizuho and Jefferies to $200. After-hours trading was subdued as investors digested a Form 4 showing CEO Tim Archer sold 163,300 shares at $163.86 each under a prearranged 10b5-1 plan, generating about $26.8 million in gross proceeds.
19 December 2025

Stock Market Today

  • Morningstar Warns SpaceX Valuation May Fall Below Half Its $1.75 Trillion IPO Price
    June 21, 2026, 9:27 PM EDT. Morningstar analysts cast doubt on SpaceX's lofty $2.44 trillion valuation, more than 40% above its $1.75 trillion initial public offering (IPO) price. The firm highlights SpaceX's lack of profitability, earnings before interest, taxes, depreciation, and amortization (EBITDA), and dividends as key concerns. Historically, most IPOs underperform in their first year, often falling as much as 55%. Despite operational dominance with over 80% of global mass launches and a 99% mission success rate, SpaceX faces skepticism. The company's Starlink satellite network serves 164 markets, and recent acquisition of AI firm xAI could boost revenue. By contrast, aerospace peer RTX, with $22 billion revenue and profitability, trades at a $249.9 billion market cap. Early trading for SpaceX shows volatility, reflecting investor caution.

Latest articles

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

22 June 2026
Cognizant shares plunged 10.49% to $43.70, erasing $2.4 billion in equity value—more than its $2 billion 2026 buyback target—after Accenture’s narrowed growth outlook, a Berenberg downgrade, and looming Nasdaq-100 removal, even as S&P 500 and Nasdaq rallied; investors now eye Q2 guidance as the next key test.
Pentagon Could Outpace Tech Giants on Small Nuclear Projects

Pentagon Could Outpace Tech Giants on Small Nuclear Projects

22 June 2026
Valar Atomics’ Ward 250 became the first DOE-authorized advanced reactor built outside a national lab to achieve criticality, signaling a shift as U.S. defense demand accelerates small nuclear deployment, with the Army allocating over $2 billion for microreactors—moving the sector from policy to production and raising near-term demand expectations.
Go toTop